Search This Blog

Monday, August 5, 2019

Heron Therapeutics EPS in-line, beats on revenue

Heron Therapeutics (NASDAQ:HRTX): Q2 GAAP EPS of -$0.63 in-line.
Revenue of $36.7M (+112.1% Y/Y) beats by $5.27M.
Shares +1% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)